Thoracic empyema in high-risk patients: Conservative management or surgery?

Asian Cardiovascular and Thoracic Annals

Volumn 18, Issue 4, 2010, Pages 337-343

  Bar, Ilan ^a   Stav, David ^a   Fink, Gershon ^a   Peer, Amir ^a   Lazarovitch, Tsilia ^a   Papiashvilli, Michael ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Drainage; Empyema; Fibrinolysis; Pleural; Pleural Effusion; Pneumonia

Indexed keywords

ANTIBIOTIC AGENT; UROKINASE; WARFARIN;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BACTERIAL INFECTION; COMORBIDITY; CONSERVATIVE TREATMENT; CORONARY ARTERY BYPASS GRAFT; FEMALE; FIBRINOLYTIC THERAPY; FOREIGN BODY; HEMATOTHORAX; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; LOBECTOMY; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; MORTALITY; PLEURA EMPYEMA; RETROSPECTIVE STUDY; SURVIVAL; THORACOCENTESIS; THORAX BLUNT TRAUMA; THORAX DRAINAGE; TREATMENT FAILURE; TUMOR CELL DESTRUCTION; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ADULT; AGED; COMORBIDITY; EMPYEMA, PLEURAL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; ISRAEL; MALE; MIDDLE AGED; PATIENT SELECTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; THORACIC SURGICAL PROCEDURES; THROMBOLYTIC THERAPY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 77957148463     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/0218492310375752     Document Type: Article

References (20)

1. Chapman SJ, Davies RJ. The management of pleural space infections [Review]. Respirology 2004;9:4-11.
2. De Hoyos A, Sundaresan S. Thoracic empyema [Review]. Surg Clin N Am 2002;82:643-71.
3. Magovern CJ, Rusch VW. Parapneumonic and post-traumatic pleural space infections [Review]. Chest Surg Clin N Am 1994;4:561-82.
4. Mandal AK, Thadepalli H, Mandal AK, Chettipalli U. Posttraumatic empyema thoracis: a 24-year experience at a major trauma center. J Trauma 1997;43:764-71.
5. Riquet M, Hubsch JP, Le Pimpec Barthes F, Abitbol P, Souilamas R, Zukerman C, et al. Purulent pleurisy and lung cancer. Non-iatrogenic forms and therapeutic management. Rev Mal Respir 1999;16:817-22.
6. Mouroux J, Riquet M, Padovani B, Debesse B, Richelme H. Surgical management of thoracic manifestations in human immu-nodeficiency virus-positive patients: indications and results. Br J Surg 1995;82:39-43.
7. Lee RB. Benign pleural disease. Empyema thoracis. In: Selke FW, Swanson SJ, del Nido PJ, editors. Sabiston & Spencer Surgery of the Chest. Vol 1. 7th edn. Elsevier Saunders, Philadelphia, 2005:431-5.
8. Ozol D, Oktem S, Erdinc E. Complicated parapneumonic effusion and empyema thoracis: microbiologic and therapeutic aspects. Respir Med 2006;100:286-91.
9. Anstadt MP, Guill CK, Ferguson ER, Gordon HS, Soltero ER, Beall Jr AC, et al. Surgical versus nonsurgical treatment of empyema thoracis: an outcomes analysis. Am J Med Sci 2003;326:9-14.
10. Hatzinger M, Kwon ST, Langbein S, Kamp S, Häcker A, Alken P. Hans Christian Jacobaeus: inventor of human laparoscopy and thoracoscopy. J Endourol 2006;20:848-50.
11. Tillett WS, Sherry S, Read CT. The use of streptokinase-streptodornase in the treatment of postpneumonic empyema. J Thorac Surg 1951;21:275-97.
12. Molnar TF. Current surgical treatment of thoracic empyema in adults [Review]. Eur J Cardiothorac Surg 2007;32:422-30.
13. Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT. Intrapleural streptokinase for empyema and com-plicated parapneumonic effusions. Am J Respir Crit Care Med 2004;170:49-53.
14. Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infec-tion. Thorax 1997;52:416-21.
15. Bouros D, Schiza S, Patsourakis G, Chalkiadakis G, Panagou P, Siafakas NM. Intrapleural streptokinase versus urokinase in the treatment ofcomplicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med 1997;155:291-5.
16. Chin NK, Lim TK. Controlled trial ofintrapleural streptokinase in the treatment of pleural empyema and complicated parapneumo-nic effusions. Chest 1997;111:275-9.
17. Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N. Intrapleural urokinase versus normal saline in the treatment ofcomplicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med 1999;159:37-42.
18. Lee YC. Ongoing search for effective intrapleural therapy for empyema: is streptokinase the answer? Am J Respir Crit Care Med 2004;170:1-2.
19. Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miler R, et al. U.K. controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005;352:865-74.
20. Misthos P, Sepsas E, Konstantinou M, Athanassiadi K, Skottis I, Lioulias A. Early use of intrapleural fibrinolytics in the manage-ment of postpneumonic empyema. A prospective study. Eur J Cardiothorac Surg 2005;28:599-603.